|
SPG11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.322600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.488200E-01 |
| Normal-vs-Stage2 |
2.357400E-01 |
| Normal-vs-Stage3 |
1.703990E-01 |
| Normal-vs-Stage4 |
1.024570E-01 |
| Stage1-vs-Stage2 |
5.849400E-01 |
| Stage1-vs-Stage3 |
2.867900E-02 |
| Stage1-vs-Stage4 |
1.313890E-02 |
| Stage2-vs-Stage3 |
3.892300E-02 |
| Stage2-vs-Stage4 |
5.068500E-02 |
| Stage3-vs-Stage4 |
7.883200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.470600E-01 |
| Normal-vs-AfricanAmerican |
3.120200E-01 |
| Normal-vs-Asian |
3.567800E-01 |
| Caucasian-vs-AfricanAmerican |
9.153000E-01 |
| Caucasian-vs-Asian |
3.081600E-01 |
| AfricanAmerican-vs-Asian |
2.887600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.200000E-01 |
| Normal-vs-Female |
1.941230E-01 |
| Male-vs-Female |
5.082200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.128400E-01 |
| Normal-vs-Extreme_Weight |
5.688000E-01 |
| Normal-vs-Obese |
4.590400E-01 |
| Normal-vs-Extreme_Obese |
4.146200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.109600E-01 |
| Normal_Weight-vs-Obese |
7.166600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.718600E-01 |
| Extreme_Weight-vs-Obese |
7.657400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.951600E-01 |
| Obese-vs-Extreme_Obese |
6.975400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.687800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.926500E-02 |
| Normal-vs-Age(61-80Yrs) |
4.343000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.463000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.160200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.464200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.938800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.691800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.323440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.174400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.693700E-02 |
| Normal-VS-Type2 PRCC |
8.933600E-01 |
| Normal-VS-KIRP CIMP |
2.573400E-04 |
| Normal-VS-Unclassified PRCC |
3.225000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.858150E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.78849999996367E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
5.813400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.794900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
3.008000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.58400000000292E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.786800E-01 |
| Normal-vs-N1 |
7.000000E-02 |
| Normal-vs-N2 |
1.991580E-01 |
| N0-vs-N1 |
1.838030E-01 |
| N0-vs-N2 |
4.013200E-01 |
| N1-vs-N2 |
9.035000E-01 |
|
|
